Clinical trial studies drug’s ability to prevent diabetes

February 17, 2004

The Texas Diabetes Institute, a partnership of the Health Science Center and the University Health System, is recruiting individuals for a four-year clinical trial of pioglitazone (brand name Actos) for the prevention of type 2 diabetes.